Trial Summary
What is the purpose of this trial?
This trial tests if stimulating arm muscles and sending gentle electrical signals through the tongue can help stroke patients recover better. It targets adults who have trouble moving their arms and hands after a stroke. The treatment uses a brain-computer system to help retrain the brain and muscles to work together.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment BCI-FES for stroke recovery?
Research shows that BCI-FES, which combines brain-computer interface technology with electrical stimulation, can improve brain activation and motor function in stroke patients. Studies found that BCI-FES was more effective than electrical stimulation alone in enhancing brain activity and motor control.12345
Is brain stimulation for stroke recovery safe for humans?
How is the BCI-FES treatment for stroke recovery different from other treatments?
The BCI-FES treatment is unique because it combines brain-computer interface technology with functional electrical stimulation to enhance motor recovery after a stroke. This approach provides real-time feedback and stimulates brain activation more effectively than traditional electrical stimulation alone, potentially leading to better recovery outcomes.12347
Research Team
Vivek Prabhakaran, MD, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for stroke survivors with moderate arm impairment, who were independent before their stroke. It's not for those allergic to electrode gel or metals, pregnant women, people with MRI contraindications, infectious diseases, or oral lesions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Participants undergo pre-intervention MRI and behavioral testing
Treatment
Participants receive EEG-BCI training with muscle and tongue stimulation
Follow-up
Participants are monitored for changes in EEG/fMRI and behavioral measures
Treatment Details
Interventions
- BCI-FES (Neurostimulation Device)
- RecoveriX (Neurostimulation Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Robert Drape
University of Wisconsin, Madison
Chief Executive Officer since 2007
Executive MBA from the University of Wisconsin – Madison, Bachelor's degree in Biology from Augustana College (IL)
Dr. Ciara Barclay-Buchanan
University of Wisconsin, Madison
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
American Heart Association
Collaborator
Eduardo Sanchez
American Heart Association
Chief Medical Officer since 2013
MD from University of Texas Southwestern Medical School, MPH from UT Health Science Center at Houston, MS in Biomedical Engineering from Duke University
Katrina McGhee
American Heart Association
Chief Executive Officer since 2020
MBA from the University of Texas at Arlington